Warhound
Warhound develops working dogs for military, law-enforcement and emergency-response teams.
$200MSeed
ParticipantBC
Breyer Capital
Activity from announced rounds
Activity in this selectionOct 24, 2026 · Biotech · Jan 1, 2026
- Rounds participated in
- 5
- Confirmed lead rounds
- 0 3 roles undisclosed
- New companies
- 5 First participation on record · 0 follow-on
- Funding in participating rounds
- $598M 5 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
5 in this selectionSoufflé Therapeutics
Soufflé Therapeutics develops targeted RNA medicines for patients with muscle disorders and heart failure.
$135MSeries B
ParticipantNetwork Bio
Builds AI models trained on patient tissue and clinical data for disease diagnostics
$50MStrategic
Role not disclosedParcelBio
Develops potent and durable mRNA medicines using the APEXm platform for autoimmune and oncology
$13MSeed
Role not disclosedSoley Therapeutics
Uses cells as sensors to uncover first-in-class medicines
$200MSeries C
Role not disclosed